Prenatal diagnosis of thyroid hormone resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 2, 1999, Pages 405-410

  Asteria, C ^a   Rajanayagam, O ^d   Collingwood, T N ^d   Persani, L ^a   Romoli, R ^a   Mannavola, D ^a   Zamperini, P ^b   Buzi, F ^d   Ciralli, F ^d   Chatterjee, V K K ^d   Beck Peccoz, P ^a,c  

^a SAN PAOLO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIOTHYRONINE; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROTROPIN; THYROXINE; TIRATRICOL;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; CORDOCENTESIS; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GOITER; HETEROZYGOSITY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; MULTIPLE ORGAN FAILURE; NEWBORN; POINT MUTATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RECEPTOR GENE; RESPIRATORY DISTRESS SYNDROME; THYROID HORMONE RESISTANCE;

POMACANTHUS MACULOSUS;

EID: 0032977512     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.2.5479     Document Type: Article

References (35)

1. 1. Refetoff S, Weiss RE, Usala S. 1993 The syndromes of resistance to thyroid hormone. Endocr Rev. 14:384-399.
2. 2. Beck-Peccoz P, Asteria C, Mannavola D. 1997 Resistance to thyroid hormone. In: Braverman LE, ed. Contemporary endocrinology: disease of the thyroid. Totowa, NJ: Humana Press; 199-239.
3. 3. Weiss RE, Weinberg M, Refetoff S. 1993 Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosineguanine-rich areas of the thyroid hormone receptor beta gene. J Clin Invest. 91:2408-2415.
4. 4. Adams M, Matthews C, Colllingwood TN, Tone Y, Beck-Peccoz P, Chatterjee VKK. 1994 Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the hormone receptor β gene. J Clin Invest. 94:506-515.
5. 5. Hayashi Y, Weiss RE, Same DH, et al. 1995 Do clinical manifestation of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-β receptors? J Clin Endocrinol Metab. 80:3246-3256.
6. 6. Brucker-Davis F, Scarulis MC, Grace MB, Benichou J, Hauser P, Weintraub BD. 1995 Genetic and clinical features in 42 kindreds with resistance to thyroid hormone. Ann Intern Med. 123:572-583.
7. 7. Spanheimer RG, Bar RS, Hayford JC. 1982 Hyperthyroidism caused by inappropriate thyrotropin secretion. Arch Intern Med. 142:1283-1289.
8. 8. Magner JA, Petrick P, Menezes-Feneira MM, Stelling M, Weintraub BD. 1986 Familial generalized resistance of thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125 I]triiodothyronine to fibroblast nuclei. J Endocrinol Invest. 9:459-469.
9. 9. Beck-Peccoz P, Piscitelli G, Cattaneo MG, Faglia G. 1983 Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC). J Endocrinol Invest. 6:217-223.
10. 10. Persani L, Asteria C, Tonacchera M, Vitti P, Chatterjee VKK, Beck-Peccoz P. 1994 Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab. 78:1034-1039.
11. 11. Weiss RE, Balzano S, Scherberg NH, Refetoff S. 1990 Neonatal detection of generalized resistance to thyroid hormone. JAMA. 264:2245-2250.
12. 12. Wong GWK, Shek CC, Lam STS, Tsui MKM, Leung SSF. 1995 Detection of resistance to thyroid hormone by cord blood screening. Acta Paediatr. 84:335-336.
13. 13. Salmela PI, Wide L, Juustila H, Ruokonen A. 1988 Effects of thyroid hormones (T4, T3), bromocriptine and TRIAC on inappropriateTSH hypersecretion. Clin Endocrinol (Oxf). 28:497-507.
14. 14. Aguilar Diosdado M, Escobar-Jimenez L, Fernandez Soto ML, Garcia Curiel A, Escobar-Jimenez F. 1991 Hyperthyroidism due to a familial pituitary resistance to thyroid hormone: successful control with 3,5,3' triiodothyroacetic associated to propranolol. J Clin Invest. 14:663-668.
15. 15. Takeda T, Suzuki S, Liu RT, DeGroot LJ. 1995 Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab. 80:2033-2040.
16. 16. Beck-Peccoz P, Cortelazzi D, Baggiani AM, Marconi AM, Buscaglia M. 1993 Evidence for transplacental passage of 3,5,3' triiodothyroacetic acid (TRIAC) in pregnant women. Proc 67th Meeting of the American Thyroid Association, November 10-14, Tampa, FL (T-1:2 Abs).
17. 17. Nicolini U, Venegoni E, Acaia B, Cortelazzi D, Beck-Peccoz P. 1996 Prenatal hypothyroidism: is there more than one option? Prenat Diagn. 16:443-448.
18. 18. Chatterjee VKK, Lee J, Rentoumis A, Jameson JL. 1989 Negative regulation of the thyroid stimulating hormone α gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc Natl Acad Sci USA. 86:9114-9118.
19. 19. Collingwood TN, Adams M, Tone Y, Chatterjee VKK. 1994 Spectrum of transcriptional, dimerization and dominant negative properties of twenty different mutant thyroid hormone β receptors in thyroid hormone resistance syndrome. Mol Endocrinol. 8:1262-1277.
20. 20. Adams M, Nagaya T, Tone Y, Jameson JL, Chatterjee VK. 1992 Functional properties of a novel mutant thyroid hormone receptor in a family with generalized thyroid hormone resistance syndrome. Clin Endocrinol (Oxf). 36:281-289.
21. 21. Daffos F, Capella-Pavlovsky M, Forestier F. 1983 A new procedure for fetal blood sampling in utero: preliminary results of fifty-three cases. Am J Obstet Gynecol. 146:985-987.
22. 22. Persani L, Tonacchera M, Beck-Peccoz P, et al. 1993 Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin. J Endocrinol Invest. 16:511-519.
23. 23. Achiron R, Rotstein Z, Lipitz S, Karasik A, Seidman DS. 1998 The development of foetal thyroid: in utero ultrasonographic measurements. Clin Endocrinol (Oxf). 48:259-264.
24. 24. Beck-Peccoz P, Cortelazzi D, Persani L, et al. 1992 Maturation of pituitarythyroid function in the anencephalic fetus. Acta Med Austr. 19 [Suppl 1]:72-76.
25. 25. Usala SJ, Menke JB, Watson TL, et al. 1991 A homozygous deletion in the C-erbAβ thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor. Mol Endocrinol. 61:1119-1126.
26. 26. Persani L, Borgato S, Romoli R, Asteria C. Pizzocaro A, Beck-Peccoz P. 1998 Changes in the silylation degree of carbohydrate chains modify the biological properties of circulating TSH isoforms in various physiological and pathological status. J Clin Endocrinol Metab. 83:2486-2492.
27. 27. Perelman AH, Johnson RL, Clemons RD, Finberg HJ, Clewell WH, Tujillo L. 1990 Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism. J Clin Endocrinol Metab. 71:618-621.
28. 28. Cheron RG, Kaplan MM, Selenkow HA, Crigler Jr JF. 1981 Neonatal thyroid function after propylthiouracyl therapy for maternal Graves' disease. N Engl J Med. 304:525-528.
29. 29. Momotani N, Noh J, Oyanagy H, Ishikawa N, Ito K. 1986 Antithyroid drug therapy of Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med. 315:24-28.
30. 30. Helton TE, Magner JA. 1994 Sialyltranferase messenger ribonucleic acid increases in thyrotrophs of hypothyroid mice: an in situ hybridization study. Endocrinology. 134:2347-2353.
31. 31. Helton TE, Magner JA. 1994 β-1,4-galactosyltransferase and α-mannosidase-II messenger ribonucleic acid levels increase with different kinetics in thyrotrophs of hypothyroid mice. Endocrinology. 135:1980-1985.
32. 32. Persani L, Cortelazzi D, Asteria C, Giammona E, Mannavola D, Beck-Peccoz P. 1996 Modification of secretion, ricin lectin-binding and bioactiviry of TSH from patients with resistance to thyroid hormone (RTH) treated with triiodothyro-acetic acid (TRIAC). Tenth International Congress of Endocrinology, San Francisco (Vol I:OR40-1 Abs).
33. 33. Vulsma T, Joke HK. 1996 Prematurity-associated neurologic and developmental abnormalities and neonatal thyroid function. N Engl J Med. 28:857-858.
34. 34. Reuss ML, Paneth N, Pino-Martin JA, Lorenz JM, Susser M. 1996 The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med. 334:821-827.
35. 35. Behr M, Ramsden DB, Loos U. 1997 Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbAβ1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone. J Clin Endocrinol Metab. 82:1081-1087.